DNA amplification at 11q13 in human cancer: from complexity to perplexity.

[1]  C. Theillet,et al.  Amplification of 11q13 DNA sequences in human breast cancer: D11S97 identifies a region tightly linked to BCL1 which can be amplified separately. , 1992, Oncogene.

[2]  B. C. Misra,et al.  Loss of heterozygosity for alleles on chromosome II in cervical carcinoma. , 1991, American journal of human genetics.

[3]  O. Melnyk,et al.  Characterization of a candidate bcl-1 gene , 1991, Molecular and cellular biology.

[4]  T. Hunter,et al.  Cyclins and cancer , 1991, Cell.

[5]  C. Nguyen,et al.  D11S146 and BCL1 are physically linked but can be discriminated by their amplification status in human breast cancer. , 1991, Genomics.

[6]  B. Futcher,et al.  Human D-type cyclin , 1991, Cell.

[7]  D. Birnbaum,et al.  Localization of the HST/FGFK gene with regard to 11 q 13 chromosomal breakpoint and fragile site , 1991, Genes, chromosomes & cancer.

[8]  J. Cairns,et al.  Amplification at chromosome 11q13 in transitional cell tumours of the bladder. , 1991, Oncogene.

[9]  M. Imamura,et al.  Deletion of 17p and amplification of the int-2 gene in esophageal carcinomas. , 1991, Cancer research.

[10]  A. Arnold,et al.  A novel cyclin encoded by a bcl1-linked candidate oncogene , 1991, Nature.

[11]  D. Birnbaum,et al.  BEK and FLG, two receptors to members of the FGF family, are amplified in subsets of human breast cancers. , 1991, Oncogene.

[12]  T. Shows,et al.  Rearrangement and overexpression of D11S287E, a candidate oncogene on chromosome 11q13 in benign parathyroid tumors. , 1991, Oncogene.

[13]  T. Maudelonde,et al.  Decrease of c-erbB-2 and c-myc RNA levels in tamoxifen-treated breast cancer. , 1991, Oncogene.

[14]  E. Schuuring,et al.  D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. , 1991, Oncogene.

[15]  Y. Kitagawa,et al.  Significance of int-2/hst-1 coamplification as a prognostic factor in patients with esophageal squamous carcinoma. , 1991, Cancer research.

[16]  C. Basilico,et al.  The K-fgf/hst oncogene induces transformation through an autocrine mechanism that requires extracellular stimulation of the mitogenic pathway , 1991, Molecular and cellular biology.

[17]  M. Fernö,et al.  Association of INT2/HST1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis. , 1991, British Journal of Cancer.

[18]  G. Peters,et al.  Cell transformation by Int-2--a member of the fibroblast growth factor family. , 1991, Oncogene.

[19]  M. Maltoni,et al.  Heterogeneous protooncogene amplification correlates with tumor progression and presence of metastases in gastric cancer patients. , 1990, Cancer research.

[20]  F. Mitelman,et al.  Frequent rearrangement of chromosomal bands 1p22 and 11q13 in squamous cell carcinomas of the head and neck , 1990, Genes, chromosomes & cancer.

[21]  R. Figlin,et al.  Frequent amplification of the bcl-1 locus in poorly differentiated squamous cell carcinoma of the lung. The Lung Cancer Study Group. , 1990, Oncogene.

[22]  D. Birnbaum,et al.  The 11q13 amplicon of a mammary carcinoma cell line , 1990, Genes, chromosomes & cancer.

[23]  H. Ito,et al.  Alterations of oncogenes in metastatic tumours of human gastric carcinomas. , 1990, British Journal of Cancer.

[24]  G M Clark,et al.  How to use prognostic factors in axillary node-negative breast cancer patients. , 1990, Journal of the National Cancer Institute.

[25]  D. Moscatelli,et al.  A murine fibroblast growth factor (FGF) receptor expressed in CHO cells is activated by basic FGF and Kaposi FGF. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[26]  K. Somers,et al.  Amplification of the int-2 gene in human head and neck squamous cell carcinomas. , 1990, Oncogene.

[27]  Joseph Schlessinger,et al.  Signal transduction by receptors with tyrosine kinase activity , 1990, Cell.

[28]  T. Tlsty.  Normal diploid human and rodent cells lack a detectable frequency of gene amplification. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[29]  G. Peters,et al.  Gene amplification on chromosome band 11q13 and oestrogen receptor status in breast cancer. , 1990, European journal of cancer.

[30]  P. Leder,et al.  The int‐2 gene product acts as an epithelial growth factor in transgenic mice. , 1990, The EMBO journal.

[31]  F. Watt,et al.  DNA amplification is rare in normal human cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[32]  R. Lupu,et al.  Autocrine growth stimulation by secreted Kaposi fibroblast growth factor but not by endogenous basic fibroblast growth factor. , 1990, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[33]  D. Birnbaum,et al.  BCL-1 participates in the 11q13 amplification found in breast cancer. , 1990, Oncogene.

[34]  B H Margolin,et al.  Differences in the rates of gene amplification in nontumorigenic and tumorigenic cell lines as measured by Luria-Delbrück fluctuation analysis. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[35]  C. Theillet,et al.  Proto-oncogene amplification and human breast tumor phenotype. , 1989, Oncogene.

[36]  T. Sugimura,et al.  High incidence of coamplification of hst-1 and int-2 genes in human esophageal carcinomas. , 1989, Cancer research.

[37]  G. Merlo,et al.  Expression of int-2 mRNA in human tumors amplified at the int-2 locus. , 1989, Oncogene.

[38]  J. Yang,et al.  Frequent amplification of the bcl-1 locus in head and neck squamous cell carcinomas. , 1989, Oncogene.

[39]  G. Peters,et al.  The mouse homolog of the hst/k-FGF gene is adjacent to int-2 and is activated by proviral insertion in some virally induced mammary tumors. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[40]  D. Birnbaum,et al.  Amplification of FGF-related genes in human tumors: possible involvement of HST in breast carcinomas. , 1989, Oncogene.

[41]  G. Wahl,et al.  Recent progress in understanding mechanisms of mammalian DNA amplification , 1989, Cell.

[42]  G. Stark,et al.  Evolution and stability of chromosomal DNA coamplified with the CAD gene , 1989, Molecular and cellular biology.

[43]  S. Hirohashi,et al.  Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units: hst-1/int-2 and c-erbB-2/ear-1. , 1989, Cancer research.

[44]  G. Wahl,et al.  The importance of circular DNA in mammalian gene amplification. , 1989, Cancer research.

[45]  J. Bishop,et al.  The PVT gene frequently amplifies with MYC in tumor cells , 1989, Molecular and cellular biology.

[46]  J. Hamlin,et al.  Identification and characterization of a gene that is coamplified with dihydrofolate reductase in a methotrexate-resistant CHO cell line , 1989, Molecular and cellular biology.

[47]  T. Sugimura,et al.  HST1 and INT2 gene coamplification in a squamous cell carcinoma of the gallbladder. , 1989, Japanese journal of clinical oncology.

[48]  G. Merlo,et al.  The amplification unit on chromosome 11q13 in aggressive primary human breast tumors entails the bcl-1, int-2 and hst loci. , 1989, Oncogene.

[49]  D. Birnbaum,et al.  The FGF-related oncogenes hst and int.2, and the bcl.1 locus are contained within one megabase in band q13 of chromosome 11, while the fgf.5 oncogene maps to 4q21. , 1988, Oncogene.

[50]  T. Ochiya,et al.  Co-amplification of integrated hepatitis B virus DNA and transforming gene hst-1 in a hepatocellular carcinoma. , 1988, Oncogene.

[51]  D. Rifkin,et al.  Processing, secretion, and biological properties of a novel growth factor of the fibroblast growth factor family with oncogenic potential , 1988, Molecular and cellular biology.

[52]  D. Birnbaum,et al.  Chromosomal localization of the hst oncogene and its co-amplification with the int.2 oncogene in a human melanoma. , 1988, Oncogene.

[53]  C. Larsson,et al.  Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma , 1988, Nature.

[54]  G. Casey,et al.  Amplification of human int-2 in breast cancers and squamous carcinomas. , 1988, Oncogene.

[55]  G. Peters,et al.  Amplification of the int-2 gene in primary human breast tumors. , 1988, Oncogene research.

[56]  G. Stark,et al.  Hamster cells with increased rates of DNA amplification, a new phenotype , 1987, Cell.

[57]  F. Haluska,et al.  Mechanisms of chromosome translocation in B- and T-cell neoplasia , 1987 .

[58]  P. Nowell,et al.  Clustering of breakpoints on chromosome 11 in human B-cell neoplasms with the t(11 ; 14) chromosome translocation , 1985, Nature.

[59]  J. Mendelsohn,et al.  Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[60]  G. Gill,et al.  Increased phosphotyrosine content and inhibition of proliferation in EGF-treated A431 cells , 1981, Nature.